Company Overview

Creative Edge Nutrition, Inc. (OTC Pink: FITX) is a publicly traded micro-cap company that historically operated in the nutritional supplement and wellness sector, with periods of announced expansion into cannabis-related ventures and health-product development. Public filings and OTC market disclosures indicate that the company’s activities have evolved over time, including corporate restructuring efforts, changes in operating focus, and periods of limited disclosed operating activity. Available public information suggests the company has pursued opportunities tied to sports nutrition, health supplements, and cannabinoid-related business initiatives, although the extent of active commercial operations has not always been consistently documented in recent filings.

The company became widely known in retail investor circles during the mid-2010s due to proposed cannabis cultivation and wellness projects associated with CEN Biotech Inc., a subsidiary referenced in historical corporate materials. However, multiple public records, regulatory disclosures, and market commentary indicate that several proposed initiatives faced regulatory and operational challenges. Based on publicly available filings and OTC disclosures, the company’s current operational scale, revenue-generating capacity, and active business footprint remain difficult to independently verify in detail. Data inconclusive based on available public sources.

Business Operations

Historically, Creative Edge Nutrition reported operations connected to nutritional products, wellness formulations, and proposed cannabis cultivation infrastructure. Public disclosures referenced business units and subsidiaries including CEN Biotech Inc., which was associated with planned medical cannabis production activities in Canada. The company also referenced supplement distribution and health-oriented consumer products as part of its broader business strategy. Revenue generation mechanisms described in historical materials included product sales, licensing opportunities, and planned cultivation operations, though independently verifiable recurring revenue data has been limited in recent periods.

The company’s operational disclosures indicate a predominantly North American orientation, with activities centered in the United States and Canada. Public filings and OTC disclosures suggest the company relied heavily on strategic announcements, licensing ambitions, and subsidiary development rather than large-scale established operating infrastructure. Information regarding active partnerships, material joint ventures, or currently operating production assets is limited and not consistently substantiated across recent public documentation. Data inconclusive based on available public sources.

Strategic Position & Investments

Creative Edge Nutrition’s strategic positioning historically centered on aligning wellness, nutrition, and emerging cannabis-sector opportunities during periods of rapid investor interest in alternative health and cannabinoid markets. The company publicly discussed plans involving cultivation facilities, health-product commercialization, and expansion through subsidiary structures. The proposed development of cannabis cultivation capacity through CEN Biotech Inc. represented one of the company’s most visible strategic initiatives, although regulatory approval and execution outcomes became subject to public scrutiny and uncertainty.

Publicly available information does not clearly establish a large portfolio of completed acquisitions, institutional investments, or diversified operating subsidiaries beyond historically disclosed entities. The company has periodically appeared in OTC market disclosures tied to restructuring efforts and corporate updates, but recent independently verified information regarding significant capital investments, advanced technology development, or material operating expansion remains limited. Data inconclusive based on available public sources.

Geographic Footprint

Creative Edge Nutrition has primarily been associated with operations and corporate activity in North America, particularly the United States and Canada. Historical disclosures connected the company to proposed cultivation and wellness-related operations in Ontario, Canada, while corporate registration and public market activity have been linked to the U.S. OTC market structure. The company’s investor communications historically targeted both U.S. and Canadian market participants interested in wellness and cannabis-sector developments.

There is limited evidence in recent publicly available disclosures of broad multinational operations, large-scale international manufacturing networks, or substantial overseas commercial infrastructure. Available records do not indicate a major operating presence across Europe, Asia-Pacific, Latin America, or the Middle East comparable to larger publicly traded health or cannabis companies. Data inconclusive based on available public sources.

Leadership & Governance

Publicly available leadership information for Creative Edge Nutrition has varied over time due to management changes and inconsistent reporting across OTC disclosures and corporate communications. Historical records associated several executives and company representatives with the organization during different operational periods, though current governance visibility appears limited relative to fully reporting SEC registrants. The company’s historical strategic messaging emphasized growth through emerging wellness sectors, cannabis-related opportunities, and consumer health markets.

Key individuals publicly associated with the company in historical disclosures include:

• Bill Chaaban – Former Chief Executive Officer
• Monica A. Ruf – Corporate Secretary (historically referenced in filings and disclosures)
• Michael J. Pottenger – Former executive association referenced in historical corporate materials

Because Creative Edge Nutrition has operated within the OTC market environment and disclosure practices have varied over time, some executive and governance information cannot be consistently verified across multiple recent independent public sources. Data inconclusive based on available public sources.